跳至主要内容
临床试验/NCT01624506
NCT01624506已完成不适用

Observational Study of Anti-Reflux Surgery: Clinical Experience With the LINX Reflux Management System and Fundoplication

Torax Medical Incorporated21 个研究点 分布在 4 个国家目标入组 760 人开始时间: 2010年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
760
试验地点
21
主要终点
Gastroesophageal Reflux Disease Health Related Quality of Life Outcome (GERD-HRQL)

研究概览

简要总结

The Anti-Reflux Surgical Study has been established to:

  • Collect data about anti-reflux surgical treatment options (magnetic sphincter augmentation and Fundoplication) in everyday clinical practice
  • Track the clinical course of patients from pre-operative assessment to three years post-surgery

详细描述

This study will track and monitor patients treated with either the magnetic sphincter augmentation or Fundoplication, making it the first Registry to collect data on both anti-reflux surgical options in the setting of everyday clinical experience.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Other

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Individuals treated with LINX Reflux Management System or Fundoplication
  • Individuals who have provided appropriate authorization per institutional policy and procedure to have clinical and health information collected for the Anti-Reflux Surgical Registry.
  • Individuals willing to complete questionnaires and comply with the three years of follow-up.

排除标准

  • Known circumstances that would make it unlikely for an individual to complete the three year follow-up (e.g. life expectancy <3 years)

结局指标

主要结局

Gastroesophageal Reflux Disease Health Related Quality of Life Outcome (GERD-HRQL)

时间窗: 3 years post-surgery

Gastroesophageal Reflux Disease Health Related Quality of Life Outcomes (GERD-HRQL) Total scores range from 0-50 (min/max) 10 questions total, each rating 0-5 (min/max) Lower is better; higher is worse

次要结局

未报告次要终点

研究者

发起方
Torax Medical Incorporated
申办方类型
Industry
责任方
Sponsor

研究点 (21)

Loading locations...

相似试验

Observational Study of Anti-Reflux Surgery | 临床试验